首页 | 官方网站   微博 | 高级检索  
     

神经干细胞移植联合腹腔注射促红细胞生成素对横断性脊髓损伤大鼠神经轴突的修复作用
引用本文:王喜良,赵岩,左媛,肖宇龙,霍洪军,江建明,闫慧博.神经干细胞移植联合腹腔注射促红细胞生成素对横断性脊髓损伤大鼠神经轴突的修复作用[J].吉林大学学报(医学版),2015,41(1):99-104.
作者姓名:王喜良  赵岩  左媛  肖宇龙  霍洪军  江建明  闫慧博
作者单位:1. 内蒙古医科大学第二附属医院胸腰椎脊柱外科, 内蒙古 呼和浩特 010030;
2. 内蒙古医科大学第二附属 医院检验科, 内蒙古 呼和浩特 010030;
3. 南方医科大学附属南方医院脊柱外科, 广东 广州 510515;
4. 南方医科大学第三附属医院脊柱外科, 广东 广州 510630
基金项目:内蒙古自治区科技厅自然科学基金资助课题(2011MS1139)
摘    要:目的: 探讨神经干细胞(NSCs)与促红细胞生成素(EPO)共同作用于横断性脊髓损伤大鼠后对损伤区轴突的修复作用,为临床治疗脊髓损伤提供理论依据。方法: 40只雌性成年Wistar大鼠,建立T10全横断大鼠脊髓损伤模型后,随机分为对照组、NSCs组、EPO组和联合治疗组,每组10只。术后8周采用BDA皮质脊髓束顺行追踪法和荧光金(FG)皮质脊髓束逆行追踪法评估损伤区脊髓神经轴突再生情况,同时分期采用实验性脊髓损伤运动功能BBB评分法评价大鼠后肢功能恢复情况。结果: BDA 免疫荧光染色和FG免疫荧光染色,联合治疗组可见大量被BDA-cy3红色荧光标记的再生轴突,其中部分再生轴突穿越损伤区到达远端;NSCs组仅见少量轴突再生,无神经轴突通过脊髓损伤区;EPO组偶见散在的神经纤维再生;对照组无明显的轴突再生。联合治疗组大脑皮质中可见少量被FG标记的椎体细胞及轴突发出金黄色荧光,其余3组大脑皮质中无FG标记细胞。大鼠后肢功能BBB评分,在术后1周及1周以后各时段,联合治疗组大鼠BBB评分均高于其他各组(P<0.05)。结论: 脊髓损伤后移植NSCs联合腹腔注射EPO可有效促进脊髓损伤区神经轴突的再生以及脊髓损伤大鼠后肢运动功能的恢复。

关 键 词:神经干细胞  促红细胞生成素  干细胞移植  全横断脊髓损伤  轴突再生  
收稿时间:2014-07-22

Repair effect of neural stem cells transplantation combined with intraperitoneal injection erythropoietin for axons in adult rats with transected spinal cord injury
WANG Xiliang,ZHAO Yan,ZUO Yuan,XIAO Yulong,HUO Hongjun,JIANG Jianming,YAN Huibo.Repair effect of neural stem cells transplantation combined with intraperitoneal injection erythropoietin for axons in adult rats with transected spinal cord injury[J].Journal of Jilin University: Med Ed,2015,41(1):99-104.
Authors:WANG Xiliang  ZHAO Yan  ZUO Yuan  XIAO Yulong  HUO Hongjun  JIANG Jianming  YAN Huibo
Affiliation:WANG Xiliang;ZHAO Yan;ZUO Yuan;XIAO Yulong;HUO Hongjun;JIANG Jianming;YAN Huibo;Department of Thoracolumbar Spine Surgery,Second Affiliated Hospital,Inner Mongolia Medical University;Department of Clinical Laboratory,Second Affiliated Hospital,Inner Mongolia Medical University;Department of Orthopedic and Spinal Surgery,Nanfang Hospital,Southern Medical University;Department of Spinal Surgery,Third Affiliated Hospital,Southern Medical University;
Abstract:Objective To investigate the repair effect of neural stem cells(NSCs) and erythropoietin (EPO) on the axonal regeneration of the rats with transected spinal cord injury in spinal cord injury area, and to provide theoretical basis for the clinical treatment of spinal cord injury. Methods Forty Wistar rats with T10 spinal cord transaction were randomly divided into control group, NSCs group, EPO group and NSCs+EPO group(n=10).BDA anterograde corticospinal cord neuronal tracing and fluoro-gold(FG) retrograde tracing were carried out at the 8th week after operation to observe the regeneration of nerve fibers.The BBB locomotion score was used to evaluate the restoration after operation in the rats with spinal cord transaction. Results The BDA immunofluorescence staining and FG immunofluorescence staining results showed that a large amount of regenerated axons were observed in NSCs+EPO group, which were labeled by BDA-cy3 red fluorescence, and some regenerated axons got through the injuried area.While in NSCs group, only a small amount of regenerated axons were observed after spinal cord injury, and no regenerated axons got through the injuried area.In EPO group, only sporadically regenerated nerve fibers were observed occasionally, while in control group, no axonal regeneration was observed.In NSCs+EPO group, a small amount of cones and axons, which were labeled by FG fluorescence, emitted golden yellow fluorescence, and no cells labeled by FG was observed in other groups.The BBB scores in NSCs+EPO group 7 d after operation and at different time later were higher than those in other groups(P<0.05). Conclusion Transplantated NSCs and intraperitoneal injection of EPO could promote axon regeneration in spinal cord injury zone and hind limb motor function recovery of the rats with spinal cord injury.
Keywords:neural stem cells  erythropoietin  stem cell transplantation  transected spinal cord injury  axonal regeneration
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《吉林大学学报(医学版)》浏览原始摘要信息
点击此处可从《吉林大学学报(医学版)》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号